Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 106

1.

Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).

Goicoechea M, de Vinuesa SG, Quiroga B, Verde E, Bernis C, Morales E, Fernández-Juárez G, de Sequera P, Verdalles U, Delgado R, Torres A, Arroyo D, Abad S, Ortiz A, Luño J.

Cardiovasc Drugs Ther. 2018 Jun;32(3):255-263. doi: 10.1007/s10557-018-6802-1.

PMID:
29943364
2.

Impact of anticoagulation and platelet antiaggregation on anaemia and haemorragic events in patients with chronic kidney disease stages 3 and 4.

García-Prieto A, Goicoechea M, Linares T, Panizo N, García de Vinuesa MS, Verdalles Ú, Verde E, Pérez de José A, Luño J.

Med Clin (Barc). 2018 Mar 1. pii: S0025-7753(18)30070-8. doi: 10.1016/j.medcli.2018.01.021. [Epub ahead of print] English, Spanish.

PMID:
29503026
3.

Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.

Goicoechea M, Sanchez-Niño MD, Ortiz A, García de Vinuesa S, Quiroga B, Bernis C, Morales E, Fernández-Juarez G, de Sequera P, Verdalles U, Verde E, Luño J.

Prostaglandins Leukot Essent Fatty Acids. 2017 Oct;125:8-13. doi: 10.1016/j.plefa.2017.08.009. Epub 2017 Aug 24.

PMID:
28987723
4.

Lesinurad: what the nephrologist should know.

Sanchez-Niño MD, Zheng-Lin B, Valiño-Rivas L, Sanz AB, Ramos AM, Luño J, Goicoechea M, Ortiz A.

Clin Kidney J. 2017 Oct;10(5):679-687. doi: 10.1093/ckj/sfx036. Epub 2017 May 26.

5.

Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass.

Galán I, Goicoechea M, Quiroga B, Macías N, Santos A, García de Vinuesa MS, Verdalles Ú, Cedeño S, Verde E, Pérez de José A, García A, Luño J.

Nefrologia. 2018 Jan - Feb;38(1):73-78. doi: 10.1016/j.nefro.2017.04.006. Epub 2017 Aug 30. English, Spanish.

6.

Hypokalemia due to excessive cola consumption.

García-Prieto A, Verde E, Goicoechea M.

Med Clin (Barc). 2017 Dec 20;149(12):555-556. doi: 10.1016/j.medcli.2017.06.014. Epub 2017 Jul 21. English, Spanish. No abstract available.

PMID:
28736066
7.

Cardiovascular risk prediction in chronic kidney disease patients.

Cedeño Mora S, Goicoechea M, Torres E, Verdalles Ú, Pérez de José A, Verde E, García de Vinuesa S, Luño J.

Nefrologia. 2017 May - Jun;37(3):293-300. doi: 10.1016/j.nefro.2016.10.002. Epub 2017 May 8. English, Spanish.

8.

Changes in the clinical presentation of immunoglobulin A nephropathy: data from the Spanish Registry of Glomerulonephritis.

Gutiérrez E, Praga M, Rivera F, Sevillano A, Yuste C, Goicoechea M, López-Gómez JM; all members of the Spanish Registry of Glomerulonephritis.

Nephrol Dial Transplant. 2018 Mar 1;33(3):472-477. doi: 10.1093/ndt/gfx058.

PMID:
28460086
9.

Impact of prematurity and immigration on neonatal screening for sickle cell disease.

Cortés-Castell E, Palazón-Bru A, Pla C, Goicoechea M, Rizo-Baeza MM, Juste M, Gil-Guillén VF.

PLoS One. 2017 Feb 7;12(2):e0171604. doi: 10.1371/journal.pone.0171604. eCollection 2017.

10.

HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen.

Karris MY, Jain S, Day TR, Pérez-Santiago J, Goicoechea M, Dubé MP, Sun X, Spina C, Daar ES, Haubrich RH, Morris S; California Collaborative Treatment Group (CCTG) 589 Study Team.

HIV Clin Trials. 2017 Mar;18(2):67-74. doi: 10.1080/15284336.2017.1282578. Epub 2017 Jan 30.

11.

Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis.

Verde E, Pérez de Prado A, López-Gómez JM, Quiroga B, Goicoechea M, García-Prieto A, Torres E, Reque J, Luño J.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2210-2217. Epub 2016 Oct 3.

12.

Identification and Characterization of the Dermal Panniculus Carnosus Muscle Stem Cells.

Naldaiz-Gastesi N, Goicoechea M, Alonso-Martín S, Aiastui A, López-Mayorga M, García-Belda P, Lacalle J, San José C, Araúzo-Bravo MJ, Trouilh L, Anton-Leberre V, Herrero D, Matheu A, Bernad A, García-Verdugo JM, Carvajal JJ, Relaix F, Lopez de Munain A, García-Parra P, Izeta A.

Stem Cell Reports. 2016 Sep 13;7(3):411-424. doi: 10.1016/j.stemcr.2016.08.002. Epub 2016 Sep 1.

13.

Prevalence and characteristics of patients with resistant hypertension and chronic kidney disease.

Verdalles Ú, Goicoechea M, Garcia de Vinuesa S, Quiroga B, Galan I, Verde E, Perez de Jose A, Luño J.

Nefrologia. 2016 Sep - Oct;36(5):523-529. doi: 10.1016/j.nefro.2016.04.003. Epub 2016 Jul 18. English, Spanish.

14.

Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.

Karris MY, Jain S, Bowman VQ, Rieg G, Goicoechea M, Dube MP, Kerkar S, Kemper C, Diamond C, Sun X, Daar ES, Haubrich RH, Morris S; California Collaborative Treatment Group (CCTG) 589 Study Team.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e48-50. doi: 10.1097/QAI.0000000000000990. No abstract available.

15.

Muscle wasting in myotonic dystrophies: a model of premature aging.

Mateos-Aierdi AJ, Goicoechea M, Aiastui A, Fernández-Torrón R, Garcia-Puga M, Matheu A, López de Munain A.

Front Aging Neurosci. 2015 Jul 9;7:125. doi: 10.3389/fnagi.2015.00125. eCollection 2015. Review.

16.

Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?

Verdalles U, García de Vinuesa S, Goicoechea M, Macías N, Santos A, Perez de Jose A, Verde E, Yuste C, Luño J.

Nephrology (Carlton). 2015 Aug;20(8):567-71. doi: 10.1111/nep.12475.

PMID:
25818266
17.

Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease.

Quiroga B, Galán I, García de Vinuesa S, Goicoechea M, Verdalles Ú, Luño J.

Nephrol Dial Transplant. 2015 May;30(5):801-6. doi: 10.1093/ndt/gfv059. Epub 2015 Mar 9.

PMID:
25753805
18.

Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.

Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Pérez de Jose A, Cedeño S, Linares T, Luño J.

Am J Kidney Dis. 2015 Apr;65(4):543-9. doi: 10.1053/j.ajkd.2014.11.016. Epub 2015 Jan 13.

PMID:
25595565
19.

Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus.

Caro J, Gutiérrez-Solís E, Rojas-Rivera J, Agraz I, Ramos N, Rabasco C, Espinosa M, Valera A, Martín M, Frutos MÁ, Perea L, Juárez GF, Ocaña J, Arroyo D, Goicoechea M, Fernández L, Oliet A, Hernández Y, Romera A, Segarra A, Praga M; Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN).

Nephrol Dial Transplant. 2015 Mar;30(3):467-74. doi: 10.1093/ndt/gfu306. Epub 2014 Oct 1.

PMID:
25274748
20.

Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.

Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, Oliveras A, Portolés J, Rubio E, Segura J, Aranda P, de Francisco AL, Del Pino MD, Fernández-Vega F, Górriz JL, Luño J, Marín R, Martínez I, Martínez-Castelao A, Orte LM, Quereda C, Rodríguez-Pérez JC, Rodríguez M, Ruilope LM.

Nefrologia. 2014 May 21;34(3):302-16. doi: 10.3265/Nefrologia.pre2014.Feb.12464. Epub 2014 Mar 6. English, Spanish.

Supplemental Content

Loading ...
Support Center